Neurophysiological, biomolecular and psychological predictors of response to Erenumab in chronic migraine

被引：0
|
作者：
Fiamingo, G. [1 ]
De Icco, R. [1 ]
Greco, R. [2 ]
Zanaboni, A. M. [3 ]
Bottiroli, S. [4 ]
Guaschino, E. [5 ]
Allena, M. [5 ]
Grillo, V. [5 ]
Tassorelli, C. [1 ]
Sancess, G. [5 ]
机构：
[1] Univ Pavia, IRCCS Mondino Fdn, Headache Sci Ctr, Dept Brain & Behav Sci, Pavia, Italy
[2] IRCCS Mondino Fdn, Lab Neurophysiol Integrat Auton Syst, Pavia, Italy
[3] Univ Pavia, IRCCS Mondino Fdn, Dept Brain & Behav Sci, Lab Neurophysiol Integrat Auton Syst, Pavia, Italy
[4] Giustino Fortunato Univ, IRCCS Mondino Fdn, Fac Law, Headache Sci Ctr, Pavia, Italy
[5] IRCCS Mondino Fdn, Headache Sci Ctr, Pavia, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1153
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [1] Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study
    De Icco, Roberto
    Fiamingo, Giuseppe
    Greco, Rosaria
    Bottiroli, Sara
    Demartini, Chiara
    Zanaboni, Anna Maria
    Allena, Marta
    Guaschino, Elena
    Martinelli, Daniele
    Putorti, Alessia
    Grillo, Valentina
    Sances, Grazia
    Tassorelli, Cristina
    CEPHALALGIA, 2020, 40 (12) : 1336 - 1345
  • [2] Real-life management of chronic migraine with Erenumab: correlation of clinical improvement with biomolecular and neurophysiological parameters
    De Icco, Roberto
    Fiamingo, Giuseppe
    Greco, Rosaria
    Zanaboni, Anna
    Tumelero, Elena
    Bottiroli, Sara
    Guaschino, Elena
    Allena, Marta
    Grillo, Valentina
    Tassorelli, Cristina
    Sances, Grazia
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 408 - 408
  • [3] Temporal Response Patterns to Erenumab in Patients with Chronic Migraine
    Tepper, Stewart J.
    Lucas, Sylvia
    Ashina, Messoud
    Schwedt, Todd J.
    Ailani, Jessica
    Scanlon, James V.
    Klatt, Jan
    Chou, Denise E.
    Richards, Sharon
    Lima, Gabriel Paiva da Silva
    CEPHALALGIA, 2019, 39 : 211 - 212
  • [4] Temporal Response Patterns to Erenumab in Patients with Chronic Migraine
    Tepper, S. J.
    Lucas, S.
    Ashina, M.
    Schwedt, T. J.
    Ailani, J.
    Scanlon, J., V
    Klatt, J.
    Chou, D. E.
    Richards, S.
    Lima, Paiva Da Silva G.
    HEADACHE, 2019, 59 : 97 - 98
  • [5] Timing and durability of response to erenumab in patients with chronic migraine
    Tepper, Stewart J.
    Lucas, Sylvia
    Ashina, Messoud
    Schwedt, Todd J.
    Ailani, Jessica
    Scanlon, James
    Klatt, Jan
    Chou, Denise E.
    Wang, Andrea
    da Silva Lima, Gabriel Paiva
    HEADACHE, 2021, 61 (08): : 1255 - 1263
  • [6] Sustained Response to Erenumab over Time in Patients with Chronic Migraine
    Tepper, S. J.
    Lucas, S.
    Ashina, M.
    Schwedt, T. J.
    Ailani, J.
    Scanlon, J., V
    Klatt, J.
    Chou, D. E.
    Richards, S.
    Lima, G. Paiva Da Silva
    HEADACHE, 2019, 59 : 118 - 118
  • [7] Sustained Response to Erenumab over Time in Patients with Chronic Migraine
    Tepper, Stewart J.
    Lucas, Sylvia
    Ashina, Messoud
    Schwedt, Todd J.
    Ailani, Jessica
    Scanlon, James V.
    Klatt, Jan
    Chou, Denise E.
    Richards, Sharon
    Lima, Gabriel Paiva da Silva
    CEPHALALGIA, 2019, 39 : 212 - 213
  • [8] Erenumab in Chronic Migraine: An Australian Experience
    Cheng, Shuli
    Jenkins, Bronwyn
    Limberg, Nicole
    Hutton, Elspeth
    HEADACHE, 2020, 60 (10): : 2555 - 2562
  • [9] Predictors of response to onabotulinumtoxin A in chronic migraine
    Barbanti, P.
    Egeo, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (03) : E40 - E40
  • [10] Erenumab for the treatment of chronic resistant migraine
    Layos-Romero, Almudena
    Lopez, Alberto Andres
    Bartolome, Laura Rojas
    MEDICINA CLINICA, 2022, 158 (02): : 96 - 97
12345